Social status drives desire for gene test
This article was originally published in Clinica
Executive Summary
Socio-economic status is likely to be a key factor in uptake of breast cancer gene testing, according to a multinational study of patient decision-making and outcomes. Writing in JAMA (June 26th), researchers from Canada, France and the US say only a subset of hereditary breast and ovarian cancer (HBOC) family members is likely to request BRCA1 testing when it becomes more widely available.
You may also be interested in...
QUOTED. 26 November 2020. Rachel Nuzum.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
China Poised To Conditionally Approve First COVID Vaccine
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
Novartis Faces Another Challenge To Entresto In India
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: